Diagnostic aids for the detection of oral cancer |
Bang, Kang-Mi
(Oral Cancer Center, Department of Oral and Maxillofacial Surgery, Seoul National University Dental Hospital)
Kim, Soung-Min (Oral Cancer Center, Department of Oral and Maxillofacial Surgery, Seoul National University Dental Hospital) Myoung, Hoon (Oral Cancer Center, Department of Oral and Maxillofacial Surgery, Seoul National University Dental Hospital) Kim, Myung-Jin (Oral Cancer Center, Department of Oral and Maxillofacial Surgery, Seoul National University Dental Hospital) Lee, Jong-Ho (Oral Cancer Center, Department of Oral and Maxillofacial Surgery, Seoul National University Dental Hospital) |
1 | Brinkman BM, Wong DT. Disease mechanism and biomarkers of oral squamous cell carcinoma. Curr Opin Oncol 2006;18(3):228-33. DOI ScienceOn |
2 | Funk GF, Karnell LH, Robinson RA, Zhen WK, Trask DK, Hoffman HT. Presentation, treatment, and outcome of oral cavity cancer: a National Cancer Data Base report. Head Neck 2002;24(2):165-80. DOI ScienceOn |
3 | Sandler HC. Cytological screening for early mouth cancer. Cancer 1962;15:1119 -24. DOI ScienceOn |
4 | Messadi DV, Wilder-Smith P, Wolinsky L. Improving oral cancer survival: the role of dental providers. J Calif Dent Assoc 2009;37(11):789-98. |
5 | Farah CS, McCullough MJ. A pilot case control study on the efficacy of acetic acid wash and chemiluminescent illumination (ViziLite) in the visualisation of oral mucosal white lesions. Oral Oncol 2007;43(8):820-4. DOI ScienceOn |
6 | Ram S, Siar CH. Chemiluminescence as a diagnostic aid in the detection of oral cancer and potentially malignant epithelial lesions. Int J Oral Maxillofac Surg 2005 ;34(5):521-7. DOI ScienceOn |
7 | Zhang L, Williams M, Poh CF, et al. Toluidine blue staining identifies high-risk primary oral premalignant lesions with poor outcome. Cancer Res 2005;65(17):8017-21. |
8 | Hu S, Arellano M, Boontheung P, et al. Salivary proteomics for oral cancer biomarker discovery. Clin Cancer Res 2008;14(19):6246-52. DOI ScienceOn |
9 | Franzmann EJ, Reategui EP, Pedroso F, et al. Soluble CD44 is a potential marker for the early detection of head and neck cancer. Cancer Epidemiol Biomarkers Prev 2007;16(7):1348-55. DOI ScienceOn |
10 | Nagler R, Bahar G, Shpitzer T, Feinmesser R. Concomitant analysis of salivary tumor markers--a new diagnostic tool for oral cancer. Clin Cancer Res 2006; 12(13):3979-84. DOI ScienceOn |
11 | Tavassoli M, Brunel N, Maher R, Johnson NW, Soussi T. p53 antibodies in the saliva of patients with squamous cell carcinoma of the oral cavity. Int J Cancer 1998;78(3):390-1. DOI ScienceOn |
12 | Park NJ, Zhou H, Elashoff D, et al. Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection. Clin Cancer Res 2009;15(17):5473-7. DOI ScienceOn |
13 | Wei J, Xie G, Zhou Z, et al. Salivary metabolite signatures of oral cancer and leukoplakia. Int J Cancer 2010. |